Physician profile
Priyanka Kallem
NPI 1417114067
$410.56
in general payments reported to CMS, 2019-2025
9 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Adolescent Medicine (Family Medicine) provider received nationally (typical 2025 total: $135).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $25.36 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $131.82 | 2024-2025 | Evenity, Prolia, Prolia |
| Exact Sciences Corporation | $84.26 | 2025 | The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $50.24 | 2025 | Mounjaro, Zepbound |
| Scpharmaceuticals INC. | $29.59 | 2025 | |
| Seqirus USA INC | $28.87 | 2025 | Fluad, Flucelvax |
| Heartflow, INC. | $25.45 | 2025 | |
| Pfizer INC. | $23.02 | 2025 | |
| Philips North America LLC | $18.74 | 2025 | Vest Therapy Und |
| Edwards Lifesciences Corporation | $18.57 | 2025 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priyanka Kallem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.